Download the app
App StorePlay Store
Beige
Login
← All tags

cancer

Pfizer eyes India growth wave with faster affordable launches in cancer obesity and vaccines

Pfizer eyes India growth wave with faster affordable launches in cancer obesity and vaccines

Pfizer is doubling down on India as its next growth engine, aiming to bring new medicines to market faster and at more affordable prices. The company sees major opportunity across cancer, obesity and vaccines, backed by plans for local clinical studies to support future launches and tailor outcomes for Indian patients.

Summarised by Beize from a story on The Economic Times on 13 May 2026
Hospitals warn CGHS reimbursement cap could cut off lifesaving immunotherapy for cancer patients

Hospitals warn CGHS reimbursement cap could cut off lifesaving immunotherapy for cancer patients

A major private hospital group has warned that a reimbursement cap under the Central Government Health Scheme is straining finances for hospitals treating advanced cancer. The cap on life-saving immunotherapy drugs is pushing essential medicines beyond affordability for many CGHS beneficiaries, according to the association, which says nine specific drugs are now out of reach and may limit access to treatment.

Summarised by Beize from a story on The Economic Times on 12 May 2026

Your news, in seconds

App StorePlay Store
Chinese low cost immunotherapy drugs are easing cancer bills for Indian families

Chinese low cost immunotherapy drugs are easing cancer bills for Indian families

India’s cancer care is shifting as cheaper immunotherapy drugs developed in China arrive through Indian partnerships. Oncologists say these options are expanding access for patients who cannot afford pricier Western medicines. The result, doctors claim, is less financial strain and fewer cases where cancer treatment drives families into severe debt, alongside improving affordability of sustained care.

Summarised by Beize from a story on The Economic Times on 10 May 2026
Grieving doctor builds foundation after son lost to rare cancer and gives blind children free eye surgery

Grieving doctor builds foundation after son lost to rare cancer and gives blind children free eye surgery

After her six-year-old son Hridansh died from a rare cancer, a grieving doctor turned unbearable loss into action. She co-founded the Hridansh Foundation, now helping blind children through free eye surgeries. Her personal grief became a lasting purpose, focused on restoring sight and giving families hope when they need it most.

Summarised by Beize from a story on The Economic Times on 8 May 2026
Netanyahu Underwent Surgery in Jerusalem After Prostate Cancer Treatment Details Emerge

Netanyahu Underwent Surgery in Jerusalem After Prostate Cancer Treatment Details Emerge

Israel Prime Minister Benjamin Netanyahu, 76, reportedly underwent surgery at a medical center in Jerusalem following treatment for prostate cancer. A newly shared health update describes the procedure and the immediate aftermath, offering fresh details about his condition and recovery. The disclosure comes as Netanyahu continues to lead amid regional and domestic pressure, raising fresh questions about his short-term plans.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
India’s first CAR T therapy NexCAR 19 shows promise as hospitals expand treatment nationwide

India’s first CAR T therapy NexCAR 19 shows promise as hospitals expand treatment nationwide

India’s first CAR T cell therapy, NexCAR 19, is delivering encouraging early results for a specific blood cancer. Now available at 40 hospitals, the indigenous developer ImmunoACT is scaling access and building confidence in homegrown advanced treatment. The big question: can this breakthrough meaningfully change outcomes in the fight against cancer’s toughest battles?

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Never miss a story

App StorePlay Store
How an Indian state is tackling cancer with a smarter care model

How an Indian state is tackling cancer with a smarter care model

As cancer diagnoses rise across India, particularly among younger people, one small state has rolled out a distinct care model aimed at earlier screening and faster treatment. The approach focuses on timely therapeutic intervention to improve outcomes, including better disease-free survival. The initiative highlights how organized cancer management can change the trajectory for patients facing an aggressive disease curve.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Sidhu sparks outrage claiming herbs and fasting cured his wife cancer

Sidhu sparks outrage claiming herbs and fasting cured his wife cancer

Navjot Singh Sidhu stirred controversy after claiming his wife’s advanced-stage cancer was cured using alternative remedies. His remark that fasting could kill cancer cells drew sharp criticism online. ET Prime consulted experts who cautioned that such ideas can mislead patients, risk delaying evidence-based care, and spread dangerous misconceptions about cancer treatment.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Glenmark Ichnos drug shows promise against multiple myeloma but can it beat Big Pharma

Glenmark Ichnos drug shows promise against multiple myeloma but can it beat Big Pharma

Glenmark’s Ichnos drug is showing promising results for multiple myeloma, a rare blood cancer, raising hopes for affordable breakthrough therapy. With the global market for such drugs projected to reach about USD 30 billion by decade’s end, the question is whether early clinical signals can translate into scale and pricing power against global heavyweights like J&J, Gilead, and Sanofi.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
PMJAY rule blocks oncologists and strains cancer care as burden keeps rising

PMJAY rule blocks oncologists and strains cancer care as burden keeps rising

India’s cancer crisis is worsening just as a PMJAY rule threatens to limit who can treat patients. The scheme now restricts experienced oncologists unless they hold specific degrees, potentially delaying care for many. While the government backs earlier detection and pushes down drug costs, public health demands revisiting PMJAY eligibility so vital specialists can work without unnecessary barriers.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Reading on mobile?

App StorePlay Store
Genome map could reshape how India predicts and treats cancer

Genome map could reshape how India predicts and treats cancer

A new genome reference set built around India’s diverse ethnic groups could improve cancer modelling and treatment decisions. By cataloging genetic variants that are common in different populations, researchers can create more accurate disease risk profiles and therapies designed for India’s genetic reality rather than relying on data from other regions.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026
Page 1

The full experience is on mobile.

Swipe through stories, personalise your feed, and save articles for later — all on the app.

Download on the App StoreGet it on Google Play